Alexander Hagstotz

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

German Cancer Research Center

Heidelberg University

University Hospital Carl Gustav Carus

Technische Universität Dresden

Alexander Hagstotz is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in pharmaceutics, nanomedicine, and cancer nanomedicine.

Publications per year

2019–2023

Publications

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis

Isabell Schau, Susanne Michen, Alexander Hagstotz et al. · Scientific Reports · 2019 · 33 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors

Willi Jugel, Achim Aigner, Susanne Michen et al. · Pharmaceutics · 2021 · 18 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Aurora B Kinase Inhibition by AZD1152 Concomitant with Tumor Treating Fields Is Effective in the Treatment of Cultures from Primary and Recurrent Glioblastomas

Dietmar Krex, Paula Bartmann, Doris Lachmann et al. · International Journal of Molecular Sciences · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3